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Tri-n-butyltin (TBT), a biocide, is known for its immunotoxicity and hepatotoxicity and is a well-characterised mitochondrial toxin. This
report investigates the mechanisms involved in induction of apoptosis by TBT in primary cultures of rat hepatocytes. Release of cytochrome
c from mitochondria into the cytosol was apparent after 15 min of exposure to 2.5 AM TBT. In addition, activity of initiator caspase-9
increased after 30 min, representing activation of the mitochondrial pathway in hepatocytes. The death receptor pathway was also activated
by TBT, as indicated by recruitment of the adaptor protein FADD from the cytosol to the membrane as soon as 15 min after treatment. In
addition, levels of the pro-apoptotic protein Bid decreased in the cytosol, while there was an increase in levels of the cleaved form tBid, in
TBT-treated hepatocytes. Activity of initiator caspase-8 increased after 30 min. The principal effector caspase-3 was activated following 30
min of treatment with TBT. Activation was confirmed by immunodetection of a 17-kDa cleaved fragment. Apoptotic substrates such as
Poly(ADP-ribose) polymerase and DNA fragmentation factor-45 are cleaved by caspase-3 to ensure the dismantlement of the cell. Cleavage
of Poly(ADP-ribose) polymerase into a 85-kDa fragment appeared after 30 min of TBT treatment. DNA fragmentation factor-45 disappeared
in TBT-exposed rat hepatocytes. This is the first detailed study reporting the involvement of initiator and effector caspases, cleavage of their
intracellular substrates and activation of both death receptor and mitochondrial pathways in TBT-induced apoptosis in rat hepatocytes. The
comprehension of molecular events of apoptosis is important for the evaluation of the risk to humans and animals.
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1. Introduction pesticides and as stabilizers for polyvinyl-chloride plastics.Organotin compounds, such as tributyltin (TBT), have
bactericidal and fungicidal properties. They are widely used
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1 Authors who have made similar contribution.Their presence in the marine environment is mainly due to
the use of antifouling paints on ship hulls. Recent regle-
mentation, which restricts use of this organotin compound
to larger vessels, has greatly decreased marine pollution.
However, TBT still persists in the environment and some
studies revealed its presence in daily food products like
meat, fish and milk [1–4]. Human exposure arises from
consumption of TBT-contaminated food products and oc-
cupational exposure of workers during TBT manufacture
and use of TBT-containing paints [4–6]. The main effects
of TBT on human health are skin and eye irritation and
inflammation of the respiratory tract [7,8]. In lower trophic
organisms, TBT contamination is responsible for the phe-
nomenon of imposex [9,10]. When aquatic animals and
terrestrial mammals are exposed to the organotin, it sup-
presses their immune system and makes them more vul-
nerable to infectious diseases [11–19]. Lately, measurable
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blood samples of volunteer donors [20].
TBT affects many cellular mechanisms. It is known to
inhibit oxidative phosphorylation and production of energy
[8,21,22], to reduce cyclic AMP production [23], to disturb
calcium homeostasis [24–26] and to inhibit cytochrome
P450 [27–29]. In CCRF-CEM human T lymphoblastoid
cells, TBT was found to activate mitogen-activated protein
kinases (MAPKs), leading to apoptosis [30]. TBT-induced
DNA fragmentation was observed in freshly isolated rat
thymocytes [31]. Furthermore, TBT suppresses human nat-
ural killer (NK) cells, preventing them from targeting tumor
cells [20]. Nevertheless, its exact molecular mechanism of
action is still not established.
Apoptosis is an active form of cell death, which is
essential for development and for cellular and tissue ho-
meostasis. Many proteins are involved in the molecular
signalisation of apoptosis. The caspase enzymes, for cyste-
ine-aspartyl-proteases, play a central role in the cell death
machinery. They are subdivided into initiator (caspase-2, -8,
-9 and -10) and effector (caspase-3, -6 and -7) caspases.
Caspases are synthesised as pro-enzymes, which are
cleaved at internal sites to form an active enzyme [32,33].
Their function in apoptosis is to (1) arrest the cell cycle and
inactivate DNA repair; (2) to inactivate inhibitors of apo-
ptosis (XIAP); and (3) to dismantle the cellular cytoskeleton
[32]. Usually, initiator caspases, once activated, will acti-
vate downstream effector caspases in a cascade-like pattern.
Two main pathways are well established in apoptosis: (1)
the death receptor pathway and (2) the mitochondrial
pathway.
The death receptor pathway requires membrane receptors
such as Fas, which will trimerize, then recruit an adaptor
molecule, Fas-associated death domain (FADD), and pro-
caspase-8, forming the death-inducing signaling complex
(DISC) [34]. At the DISC, procaspase-8 will be processed
and caspase-8 is activated, ensuring the direct activation of
caspase-3 [35].
Conversely, the mitochondrial pathway is activated upon
treatment with neoplasic agents, UV radiation, growth factor
withdrawal and DNA damage [35]. Following the assault,
the mitochondrial membrane potential is lost, releasing a
small apoptogenic molecule, cytochrome c, leading to
formation of the apoptosome. This is a high molecular
weight complex consisting of cytochrome c, apoptosis
protease activating factor-1 (APAF-1), dATP and procas-
pase-9, which leads to activation of caspase-9. Subsequent-
ly, this initiator caspase will activate downstream caspases,
like caspase-3. Both apoptotic pathways converge to cas-
pase-3 activation. Caspase-3 cleaves a panoply of substrates
such as Poly (ADP-ribose) polymerase (PARP), a DNA
repair enzyme, inhibitor of caspase-activated DNase (ICAD)
or DNA fragmentation factor-45 (ICAD/DFF-45), nuclear
lamins, gelsolin and fodrin [35].
The two apoptotic pathways can be linked through Bid, a
pro-apoptotic member of the Bcl-2 family of proteins [36].Bid is usually found in the cytosol and is cleaved by
caspase-8 to form a truncated protein, tBid, which will
translocate to the mitochondria and activate the mitochon-
drial pathway. This alternative is a cross-talk between the
receptor and mitochondrial pathways that can amplify
caspase activation necessary for apoptosis.
TBT has been shown to cause apoptosis in several
cellular models. In vitro studies revealed the occurrence of
apoptosis in rainbow trout hepatocytes [37], rat hepatocytes
[38], rat thymocytes [39,40], human lymphoma cells
(CCRF-CEM lymphoblastoid, Jurkat T lymphocytes and
Hut-78 cell lines) [30,41,42], human neutrophils [43] and
neuronal PC12 cells [44]. Studies in rainbow trout hepato-
cytes [37] revealed the potential implication of cysteine
proteases in TBT-induced apoptosis. TBT has been found to
increase activity of caspase-3 in Jurkat T-cell and HUT-78
lymphoma cell lines [41,45]. The precise apoptotic mecha-
nism has not yet been determined.
The reported presence of butyltin compounds in blood of
healthy human donors [20] and their hepatic deposition [46]
suggests widespread human exposure to organotin sources.
Thus, there is an increasing need to develop a suitable
animal model to monitor and investigate the effects of
butyltins and to be able to extrapolate findings to humans.
This report investigates the activation of various initiator
and executor caspases in primary cultures of rat hepatocytes
treated with 2.5 AM TBT and the cleavage of caspase-3
substrates such as PARP and ICAD/DFF-45. Here, we
investigate the involvement of the mitochondrial and death
receptor pathways in TBT-induced apoptosis. For the mito-
chondrial pathway, the liberation of cytochrome c and
activation of caspase-9 are determined. Death-receptor-me-
diated apoptosis is evaluated by means of translocation of
FADD to the cell membrane and activation of caspase-8. In
addition, we investigate whether the cleavage of Bid is
involved in amplification of the apoptotic response. The
understanding of the mode of action of different toxicants is
relevant for human and animal risk assessment.2. Materials and methods
2.1. Materials
All media for cell culture [Williams’ medium E (WME),
minimal essential medium (MEM), and modified Leibovitz-
15 (-L-15) (inspired from Ref. [47])] and gentamicin were
purchased from Gibco/Life Technologies (Burlington, ON,
CAN). Fetal bovine serum (FBS) was obtained from Immu-
nocorp (Montreal, QC, CAN). TBT, insulin, Hoechst 33258,
protease inhibitor cocktail and Ribonuclease A came from
Sigma-Aldrich (St. Louis, MO, USA). N,N,NV,NV-tetrame-
thylethylenediamine (Temed), acrylamide, bisacrylamide
and protein molecular weight standards were obtained from
Bio-Rad (Mississauga, ON, Canada). Proteinase K came
from Boehringer Mannheim (Montreal, QC, CAN). The
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Amersham Pharmacia Biotech (Piscataway, NJ, USA). All
fluorescent substrates, Ac-Asp-Glu-Val-Asp-(7-amino-4-
methylcoumarin) (Ac-DEVD-AMC) for caspase-3, Ac-
Leu-Glu-His-Asp-(7-amino-4-trifluoromethylcoumarin)
(Ac-LEHD-AFC) for caspase-9 and Z-Ile-Glu-Thr-Asp-(7-
amino-4-trifluoromethylcoumarin) (Z-IETD-AFC) for cas-
pase-8, and the caspase-3-specific inhibitor Ac-Asp-Glu-
Val-Asp-CHO (Ac-DEVD-CHO) were purchased from
Calbiochem (La Jolla, CA, USA). The anti-caspase-3
rabbit polyclonal antibody (H-277) and anti-Bid rabbit
polyclonal (FL-195) antibody came from Santa Cruz
Biotechnology (Santa Cruz, CA, USA), while the rabbit
anti-inhibitor of caspase-activated DNase (DFF-45/ICAD)
polyclonal and anti-FADD rabbit polyclonal antibodies
were purchased from Stressgen (Vancouver, BC, CAN).
The mouse monoclonal anti-cytochrome c (clone 7H8-2C12)
antibody was from Pharmingen (San Diego, CA, USA). Anti-
PARP monoclonal antibody (Clone c-2-10) was kindly do-
nated by Dr. G. Poirier (University of Laval, QC, CAN).
2.2. Methods
2.2.1. Preparation of primary cultures of rat hepatocytes
and treatment with TBT
Hepatocytes from Sprague–Dawley rats weighing 140–
180 g were isolated by a two-step perfusion technique [48].
Animals were maintained and handled in accordance with
the Canadian Council on Animal Care guidelines for the
care and use of experimental animals (CCAC Guide vol. 1,
2nd Ed., 1993). Isodensity Percoll centrifugation was used
to purify rat hepatocytes and cell viability was measured
using flow cytometry with propidium iodide staining [26].
Cell viability ranged habitually from 80% to 95%. One
million isolated hepatocytes were suspended in WME
containing 10% FBS and 0.5% gentamicin and were
seeded in 60-mm Petri dishes coated with rat tail collagen.
After 3 h at 37 jC, in a humidified atmosphere of 95% air
and 5% CO2, cells were washed using MEM to remove
dead and unattached cells and 4.5 ml of fresh L-15
medium, supplemented with 0.5% gentamicin and 0.2
Ag/ml of insulin, was added and left overnight at 37 jC.
Cells were then washed again with MEM and supplied
with fresh L-15 medium. Subsequently, they were exposed
to TBT (2.5 AM) for different times during 90 min and
apoptosis of rat hepatocytes was studied.
2.2.2. Detection of apoptosis
2.2.2.1. DNA fragmentation. Following exposure to
TBT(1.5, 2, 2.5, 3 AM for 90 min), 1106 cells were washed
twice with phosphate-buffered saline (PBS) and lysed with 50
Al of extraction buffer containing 10 mM Tris pH 8.0, 5 mM
EDTA and 0.5% SDS modified from Ref. [36]. Cell lysates
were heated for 10 min at 54 jC. Ten microliters of
Proteinase K (20 mg/ml) was added to samples, which wereincubated overnight at 54 jC. Later, 10 Al of a solution of 0.5
mg/ml of RNase Awas added for 1 h at 37 jC. DNA samples
were then heated for 10 min at 65 jC, 10 Al of loading buffer
(10 mM EDTA, 1% agarose low melting, 0.25% bromophe-
nol blue, 40% sucrose) was added and samples were loaded
onto a 2% agarose gel containing ethidium bromide (0.337
AM). Following electrophoresis for 3 h with Tris-Borate/
EDTA buffer (TBE), DNA fragmentation was visualised
under UV translumination.
2.2.2.2. Condensation of nuclear chromatin. Condensa-
tion of nuclear chromatin was visualised using Hoechst
33258 (H-33258) staining. This fluorescent dye com-
plexes with condensed DNA. Cells, which had been
exposed to 2.5 AM TBT for 0, 30, 60 or 90 min, were
washed three times with PBS and incubated with H-
33258 (50 Ag/ml in PBS) for 10 min in the dark. Then,
H-33258 was replaced with PBS and cells were visualised
by fluorescence microscopy. Apoptosis was determined by
the intensity of nuclear fluorescence in hepatocytes.
Where necessary, hepatocytes were pretreated with the
caspase-3 inhibitor (Ac-DEVD-CHO, 6 AM in 50 mM
Tris–HCl, pH 7.5), for 1 h, before incubation with the
organotin compound.
2.2.3. Enzymatic assays of caspase-3, -8 and -9 activities
Caspase-3 activity was measured by the cleavage of
DEVD-AMC, releasing AMC, according to Nicholson
et al. [49], with minor modifications. Activities of cas-
pase-8 and -9 were measured by the release of AFC from
their respective substrates. Two million hepatocytes, treated
with 2.5 AM TBT for different times (0, 15, 30, 45, 60, 75
or 90 min), were washed with PBS and 50 Al of homoge-
nisation buffer (250 mM sucrose, 1 mM EDTA, 10 mM
sodium pyrophosphate, 10 mM tricine, 2 mM MgCl2, pH
8.0) was added. Cells were sonicated for 10 s and homo-
genates were centrifuged for 1 h at 100000g at 4 jC.
Protein concentration was determined in the supernatants
using the Bradford assay [50]. Caspase assays were carried
out using 200 Ag of proteins in each microplate with the
appropriate protease assay buffer. The microplate was
incubated for 5 min at 37 jC, then the appropriate substrate
was added. For caspase-3, Ac-DEVD-AMC (50 AM) was
used as substrate in protease buffer [20 mM HEPES pH 7.5,
10% glycerol, 2 mM dithiothreitol (DTT)]. Assays for
caspase-8 and -9 were performed in protease assay buffer
containing 100 mM HEPES pH 7.5 and 10 mM DTT, using
the substrates Z-IETD-AFC (100 AM) and Ac-LEHD-AFC
(100 AM), respectively. Cleavage of substrates was moni-
tored over a period of 30 min and corresponding slopes
were obtained at appropriate wavelengths of excitation (kEx)
and emission (kEm): kEx 380 and kEm 460 for release of
AMC and kEx 400 and kEm 505 for AFC release. A
SpectraMaxGemini Spectrofluorometer (Molecular Devi-
ces, Sunnyvale, CA) was used and the slopes were obtained
by the SOFTmax Pro software (Molecular Devices).
et Bio2.2.4. Subcellular fractionation and immunodetection of
cytochrome c,FADD, caspase-3,Bid, tBid, PARPandDFF-45
Following treatment with 2.5 AM TBT for different
times (0, 15, 30, 45, 60 or 90 min), a minimum of
2106 cells were washed with PBS and harvested in
homogenisation buffer (250 mM sucrose, 1 mM EDTA-
Na2, 10 mM Na pyrophosphate, 10 mM tricine, 2 mM
MgCl2) supplemented with protease inhibitors ([4-(2-ami-
noethyl)-benzene-sulfonylfluoride] hydrochloride, aproti-
nin, bestatin, Leupeptin, pepstatin A). Lysates were
homogenised using a hand potter (Kontes glass CO, Duall
R22, Fisher, QC, Canada) and were centrifuged at 1500g
for 5 min at 4 jC. Supernatants were then centrifuged at
3640g for another 5 min at 4 jC. Supernatant samples
were then centrifuged for 10 min at 10000g at 4 jC. A
final centrifugation at 100000g at 4 jC was performed to
isolate the cytosolic fraction (supernatant), which was used
for detection of caspase-3, cytochrome c and DFF-45 by
Western blotting. For immunodetection of PARP, a whole
cell lysate was used. For the detection of FADD, Bid and
tBid, cells were removed and manually homogenised in a
lysis buffer (20 mM Tris–HCl, 5 mM EDTA, 0.3% h-
mercapthoethanol, pH 7.5, where protease inhibitors were
added freshly) according to Gomez-Angelats and Cidlow-
ski [51]. The homogenates were centrifuged at 280g for
10 min at 4 jC, and the supernatant was centrifuged at
100000g for 60 min at 4 jC. Membranes were found in
the pellet and the supernatant represents the cytosolic
fraction.
From each sample, 30–50 Ag of proteins in Laemmli’s
sample buffer [0.5 M Tris–HCl pH 6.8, 10% glycerol,
10% SDS, 0.01% bromophenol blue, 12.5% 2-mercap-
toethanol] [52] were heated for 4 min and loaded onto
either an 8, 10, 12 or 15% SDS-polyacrylamide gel.
Electrophoresis was performed at a constant voltage of
135 V for 1 h. Proteins were transferred to a polyviny-
lidene difluoride membrane using a semidry blotting
apparatus (Millipore, Seattle, USA). Blocking of nonspe-
cific sites was performed under mild agitation, either
overnight at 4 jC for caspase-3 and cytochrome c or
for 1 h at room temperature, for PARP and DFF-45, in
Tris-buffered saline with Tween (TBS+T) (2 mM Tris,
13.7 mM NaCl and 0.1% Tween 20, pH 7.4) containing
5% nonfat milk. Then, membranes were washed with
TBS+T for 1 h and primary antibody was added either
overnight at 4 jC (anti-FADD 1:4000, anti-PARP 1:10
000 and anti-DFF-45 1:1000) or for 1 h at room
temperature (anti-Bid 1:1000, anti-caspase-3 1:500 and
anti-cytochrome c 1:1000). Thereafter, membranes were
washed again and incubated 1 h with appropriate sec-
ondary antibodies conjugated to horseradish peroxidase.
Chemiluminescence was used to detect proteins (ECL kit,
Amersham, Bucks, UK). Quantitation of protein bands
was achieved by densitometry using a Molecular Dynam-
ics scanner equipped with analytical software IP lab gel
and ChemImager.
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All experiments were performed at least three times
with cell preparations obtained from different animals. All
data are reported as means and SE. The comparison of the
results from the various experimental groups relative to
their corresponding controls was carried out using one-
way analysis of variance followed by Neuman–Keuls post
hoc test. The differences were considered significant when
P < 0.05.
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3.1. TBT causes apoptosis in primary cultures of rat
hepatocytes
Morphological assessment of apoptosis in rat hepatocytes
was analysed using two approaches: DNA fragmentation and
condensation of nuclear chromatin. DNA fragmentation is an
important hallmark for apoptosis, where DNA is degraded
by nucleases such as caspase-activated DNase (CAD),
showing a characteristic ladder pattern on an agarose gel.
DNA fragmentation was examined to establish the appro-
priate concentration of TBT, which causes apoptosis in rat
hepatocytes. When hepatocytes were exposed to increasing
concentrations of TBT for 90 min, the DNA ladder pattern
appeared at 2.5 AM TBT (Fig. 1A). When hepatocytes were
exposed to 2.5 AM TBT for 90 min, the DNA ladder pattern
became apparent at 75 and 90 min (Fig. 1B). Consequently, a
concentration of 2.5 AM TBT was selected for further
analysis of apoptosis in rat hepatocytes. Ethanol (EtOH),
the control vehicle, did not induce apoptosis.
Nuclear chromatin condensation is a morphological
change, which is characteristic of apoptosis and can be
monitored using the fluorescent dye Hoechst 33258. Con-
densation of nuclear chromatin was apparent after 30 min of
treatment with 2.5 AM TBT, reaching a maximum level after
90 min. This was shown by an increase in nuclear fluores-
cence intensity compared to untreated control hepatocytes
(Fig. 2). Pretreatment of hepatocytes with an inhibitor of
caspase-3 (Ac-DEVD-CHO) inhibited TBT-induced chro-
matin condensation (Fig. 2). This indicates that the caspase
cascade is involved in the molecular mechanisms of action
of TBT toxicity in rat hepatocytes.
3.2. TBT-induced apoptosis occurs through activation of the
mitochondrial pathway
The mitochondrial pathway of apoptosis is characterised
by the release of the apoptogenic molecule cytochrome c
from mitochondria into the cytosol, leading to activation of
the initiator caspase-9. Caspase-9 activity began to increase
after 30 min of treatment with 2.5 AM TBT (Fig. 3A), and
reached a 19-fold increase after 75 min, compared to
control hepatocytes. As illustrated in Fig. 3B,C, cyto-
chrome c release into the cytosol occurred after 15 min
Fig. 1. DNA fragmentation of rat hepatocytes treated with TBT. (A)
Hepatocytes were subjected to various concentrations of TBT (0, 1.5, 2,
2.5, 3 AM) for 90 min. (B) Hepatocytes were treated with 2.5 AM TBT for
90 min. A plus (+) sign represents the TBT-treated sample and a minus ()
sign represents the vehicle [ethanol (EtOH)]. DNA fragmentation was
assessed on a 2% agarose gel containing ethidium bromide. Std is the 100-
base-pair ladder standard. The data are representative of three experiments
using different cell preparations.
Fig. 2. Morphological analysis of nuclear chromatin condensation after
exposure of rat hepatocytes to 2.5 AM TBT. A time course of treatment of
hepatocytes with 2.5 AMTBTwas followed for 90 min. Inhibition of nuclear
chromatin condensation was assessed following pretreatment for 1 h with a
caspase-3 inhibitor (Ac-DEVD-CHO, 6 AM) before exposure to 2.5 AMTBT
for 90 min. Cells were stained with Hoechst 33258 dye and all images were
taken at a magnification of 320. Images are representative of four different
experiments.
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after 75–90 min. Cytochrome c release after 15 min
preceded the increase in caspase-9 activity, which occurred
after 30 min.
3.3. TBT-induced apoptosis occurs through activation of the
death receptor pathway
The death receptor pathway involves activation of the
initiator caspase-8 through death receptors and their asso-
ciated proteins. Following treatment with 2.5 AM TBT, the
adaptor protein FADD was detected at the cellular mem-
brane level after 15 min (Fig. 4A,B). Levels of FADD
increased gradually with exposure time up to 90 min (Fig.
4B). There was a corresponding gradual decrease in levels
of FADD in the cytosol from 10 to 90 min, following
treatment with 2.5 AM TBT (Fig. 4C,D). There was no
change in cytosolic levels of FADD in control hepato-
cytes. Enzymatic activity of caspase-8 was measured
using a specific fluorescent substrate Z-IETD-AFC that,
upon cleavage by active caspase-8, releases the fluoro-chrome AFC. The activation of caspase-8 in rat hepato-
cytes was apparent after 30 min of exposure to 2.5 AM
TBT, relative to untreated control cells (Fig. 4E). A
maximum level was reached after 75 min, with a 6-fold
increase in activity.
3.4. Cleavage of pro-apoptotic protein Bid in TBT-induced
apoptosis
Caspase-8 is able to cleave Bid to form tBid, which can
amplify the activation of caspases. There was a gradual
decrease in levels of Bid in the cytosol after 30–90 min of
treatment with 2.5 AM TBT (Fig. 5A,B). There was a
corresponding increase in levels of tBid in the noncyto-
solic fraction (Fig. 5C,D). Levels of tBid gradually in-
creased from 15 to 90 min after treatment with 2.5 AM
TBT. tBid was not detected in untreated controls (data not
shown).
Fig. 3. Activation of the apoptotic mitochondrial pathway by TBT in rat hepatocytes. (A) Measurement of enzymatic activity of caspase-9 in control vs. 2.5 AM
TBT-treated cells using the substrate Ac-LEHD-AFC. (B) Western blotting of cytochrome c (15 kDa) in the cytosol of control vs. 2.5 AM TBT-treated
hepatocytes. (C) Autoradiograms of cytochrome c were analysed using a scanning laser densitometer. All data are representative of a compilation of three
distinct experiments. Error bars represent SE.
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and cleavage of its substrates
Caspase-3 is the main effector caspase involved in
apoptosis. It plays a critical role in the dismantlement of
the cell during apoptosis. Following exposure of rat hep-
atocytes to 2.5 AM TBT, there was an increase in caspase-3
enzymatic activity after 30 min. Maximum activation oc-
curred after 75 min, with a 107-fold increase compared to
control cells (Fig. 6A). Caspases are activated upon cleav-
age at internal sites and association of the large and small
subunits occurs to form an active tetramer. The native form
of procaspase-3 appears at 32 kDa and the cleaved fragment
(17 kDa) represents the active form of caspase-3 (Fig. 6B).
A small amount of active caspase-3 was observed by
immunodetection after 60 min of 2.5 AM TBT treatment(Fig. 6B,C), but higher levels were present after 90 min. The
17-kDa fragment was not detectable before 60 min (Fig.
6B), despite activation of the enzyme after 30 min (Fig. 6A).
Differing levels of sensitivity of detection for the two
techniques could explain this.
Once activated, caspase-3 cleaves many substrates, even-
tually leading to destruction of the cell. PARP (116 kDa) is
cleaved by caspase-3 into two fragments of 85 and 24 kDa.
The immunoblot indicates cleavage of PARP as soon as 30
min after treatment with 2.5 AMTBT, relative to control cells
(Fig. 7A,B). Another caspase-3 substrate is DFF-45/ICAD
(47 kDa). This protein is the chaperone of CAD. Caspase-3
will cleave the inhibitor molecule (ICAD) releasing the CAD,
which degrades DNA. The immunodetection of DFF-45
shows disappearance of the molecule with increasing time
of exposure to 2.5 AMTBT, compared to control hepatocytes
Fig. 4. Activation of the apoptotic death receptor pathway by TBT in rat hepatocytes. (A) Western blotting of FADD (29 kDa) at the membrane following
treatment with 2.5 AM TBT in rat hepatocytes. (B) Autoradiograms of FADD were analysed using a scanning densitometer. (C) Detection of cytosolic FADD
following treatment with 2.5 AM TBT in rat hepatocytes. (D) Autoradiograms of cytosolic FADD were analysed using a scanning densitometer. (E) Enzymatic
activity of caspase-8 in control vs. 2.5 AM TBT-treated cells was assessed with fluorescent substrate Z-IETD-AFC. All data represent a compilation of three
separate experiments. Error bars representFSE.
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Fig. 5. TBT activates the cross-talk pathway between the death receptor and mitochondrial pathways. (A) Western blotting of Bid (23 kDa) in the cytosolic
fraction following treatment with 2.5 AM of TBT. Bid was not detected in the noncytosolic fraction (data not shown). (B) Autoradiograms of Bid were analysed
using a laser scanning densitometer. (C) Western blot of tBid in the noncytosolic fraction of 2.5 AM TBT-treated hepatocytes. (D) Autoradiograms of tBid were
analysed using a scanning densitometer. tBid was not detected in the cytosolic fraction of TBT-treated hepatocytes nor in untreated controls (data not shown).
Data represent meansFSE from three separate experiments.
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min, reaching a minimum level after 60 min.4. Discussion
The aim of this study was to investigate the molecular
mechanisms of TBT-induced apoptosis in rat hepatocytes.
We used a detailed approach to investigate the involvement
of both the mitochondrial and death receptor pathways in
TBT-induced apoptosis. We also determined the involve-
ment of different caspases in the TBT-induced apoptotic
cascade. In rat hepatocytes, TBT caused DNA fragmentationat concentrations of 2.5–3 AM after 75–90 min, confirming
that the apoptotic phenomenon is present. In comparison
with other cellular models, a concentration of 3 AM TBT
increased DNA fragmentation in freshly isolated rat thymo-
cytes after a 10-min exposure [31]. Following TBT assault
in rainbow trout hepatocytes, the ladder pattern was appar-
ent at a concentration of 2 AM after 90 min [37]. Indeed, at
2.5 AM TBT, rainbow trout hepatocytes did not produce
DNA fragmentation, but their viability was greatly reduced
due to necrotic cell death.
Chromatin condensation in rat hepatocytes preceded the
appearance of the DNA ladder pattern, which is to be
expected. A specific caspase-3 inhibitor prevented the con-
Fig. 6. Activation of the execution phase of apoptosis by TBT in rat hepatocytes. (A) Increase in enzymatic activity of caspase-3 when hepatocytes are
subjected to 2.5 AM TBT. (B) Immunoblot of procaspase-3 and its cleaved fragment (17 kDa) after exposure to 2.5 AM TBT, relative to untreated controls. A
plus (+) sign represents the TBT-treated sample and a minus () sign represents the vehicle (EtOH). (C) Autoradiograms of the 17-kDa fragment were analysed
relative to total bands (procaspase-3 and 17-kDa fragment) using a scanning laser densitometer. Data represents meansFSE from three separate experiments.
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of caspase-3 in TBT-induced apoptosis. The broad-spectrum
caspase inhibitor, z-VAD-fmk was a potent inhibitor of TBT-
induced DNA fragmentation in rainbow trout hepatocytes
[37]. In the T cell line HUT-78, DNA fragmentation and
membrane blebbing was apparent following exposure to 2
AM TBT for 3 h [41]. Following pretreatment with z-VAD-
fmk, these morphological changes were blocked.
Cytochrome c was detected in the cytosol after 15 min of
TBT-exposure in isolated rat hepatocytes. This corresponds
to an early event in apoptosis and is in agreement with
previous studies. The upstream caspase-9 was activated in
TBT-induced apoptosis in rat hepatocytes. Caspase-9 acti-
vation was preceded by cytochrome c release. These find-
ings demonstrate that TBT activates the mitochondrial
pathway in hepatocytes. It was demonstrated that low
concentrations of TBT caused cytochrome c release from
isolated mitochondria [53]. In Jurkat lymphoma cells, cyto-chrome c liberation was observed as soon as 5 min after
exposure to 2 AM TBT and continued until 60 min [54].
TBTwas shown to activate the caspase-9, but not caspase-8,
in human platelets [55].
The present study is the first to demonstrate the
involvement of a death receptor pathway in TBT-induced
apoptosis. Our study shows translocation of FADD from
the cytosol to the cell membrane in hepatocytes treated
with 2.5 AM TBT, as well as the activation of caspase-8.
Caspase-8 activation is usually related to the death receptor
pathway; however, to our knowledge, no membrane-bound
specific receptor has been yet associated with TBT. How-
ever, Fas receptors are expressed in hepatocytes and have
been shown to be upregulated in hepatitis [56]. Hepato-
cytes also express the receptors TNF-R1, TRAIL-R1 and
TRAIL-R2 [57]. Recently, a lipocaline-like protein was
found to bind to TBT in serum of the Japanese flounder
[58]. In addition, we demonstrate the involvement of the
Fig. 7. Inactivation of caspase-3 substrates by TBT in rat hepatocytes. (A) Immunoblot of 2.5 AM TBT-induced cleavage of Poly(ADP-ribose)Polymerase was
analysed using a whole cell lysate. The band at 116 kDa represents native PARP and its cleaved fragment is at 85 kDa. (B) Laser scanning densitometry of
cleaved fragment of PARP relative to the native form. (C) Immunoblot representing the disappearance of DNA fragmentation factor-45 (DFF-45) (47 kDa)
from the cytosol of 2.5 AM TBT-treated hepatocytes. The higher molecular weight band represents nonspecific antibody binding. (D) Autoradiograms of DFF-
45 were analysed using a laser scanning densitometer. Data represent meansFSE from three separate experiments.
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receptor and mitochondrial pathways in TBT-induced ap-
optosis in hepatocytes. Bid is known to be processed by
caspase-8 to form truncated Bid (tBid). tBid can enter
mitochondria and play a role in the release of cytochrome
c [57,59]. The mechanism involving tBid is a way to
amplify apoptosis via activation of the mitochondrial
pathway [22].
Caspases are activated upon cleavage of the proenzyme
at an internal aspartate residue. Immunodetection of cas-
pase-3 showed cleavage of the pro-enzyme after 60 min of
TBT treatment in rat hepatocytes. Caspase-3 activity peaked
at 107 times that of control hepatocytes. TBT increased
catalytic caspase-3 activity in HUT-78 cells by 30 times that
of controls, after 3 h of treatment [41]. However, inplatelets, 2 AM TBT caused very rapid activation of cas-
pase-3 after 2–4 min [55].
The list of intracellular caspase substrates is still grow-
ing and caspase-3 is known to cleave a large number of
them [34]. PARP is a nuclear enzyme that is responsible
for catalysing the transfer of ADP-ribose polymers onto
itself and other nuclear proteins in response to DNA strand
breaks [60]. PARP cleavage is considered as a signature
event for apoptosis and is immunodetected in primary
cultures of rat hepatocytes exposed to 2.5 AM TBT.
Another target of caspase-3 is DFF-45/ICAD. CAD is
responsible for DNA degradation in apoptosis [61]. Dis-
appearance of DFF-45/ICAD preceded DNA fragmentation
that was noticeable after 75–90 min of TBT treatment.
The cleavage of key caspase-3 substrates is reported here
Fig. 8. Pathway of TBT-induced apoptosis in rat hepatocytes. C-3: caspase-3, C-8: caspase-8, C-9: caspase-9, Bid: pro-apoptotic protein, tBid: truncated form
of Bid, PARP: Poly(ADP-ribose)Polymerase, ICAD/DFF-45: inhibitor of CAD or DNA fragmentation factor-45, CAD: caspase-activated DNase.
M. Jurkiewicz et al. / Biochimica et Biophysica Acta 1693 (2004) 15–27 25for the first time, to our knowledge, in rat hepatocytes
following TBT-induced apoptosis.
In this report, we demonstrated the involvement of
both the mitochondrial and death receptor pathways, as
well as tBid as a linking step, in TBT-induced apoptosis
of cultured rat hepatocytes. Based on these data and
information available in the literature, we can propose a
mechanistic model of TBT-induced apoptosis in cultured
rat hepatocytes (Fig. 8). TBT could trigger apoptosis via
caspase-dependent pathways, involving both death recep-
tor(s) and mitochondria. TBT-induced changes in calcium
homeostasis are well established [37]. TBT could cause
calcium release from intracellular stores, such as the
mitochondria and endoplasmic reticulum. This could lead
to the release of cytochrome c from mitochondria. Cyto-
chrome c would participate in the apoptosome complex
leading to activation of caspase-9 and the subsequent
activation of caspase-3. On the other hand, TBT could
directly activate caspase-3, via translocation of FADD to a
death receptor complex at the cell membrane and subse-
quent activation of caspase-8. Caspase-8 is able to trun-
cate Bid to form tBid, and the latter can translocate to the
mitochondria and be involved in the release of cyto-
chrome c into the cytosol. This pathway can further
amplify the mitochondrial pathway and the activation of
caspases. The effector caspase-3 will dismantle its sub-
strates such as PARP and DFF-45/ICAD, causing DNAfragmentation and ultimately apoptotic cell death in cul-
tured rat hepatocytes.
TBT is ubiquitous in our environment and it is known to
cause much damage at the cellular level. Measurable levels
of TBT have been detected in whole blood and livers of
human volunteers [20,46]. These findings suggest that the
human population is being exposed to TBT sources without
being aware of it. A potential risk of human contamination
can arise from different sources such as antifouling paints
and fish. Due to the persistence of organotin compounds in
the environment, human risk should be assessed very
closely.Acknowledgements
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